Feb 2018

FIRST TASMANIANS APPROVED UNDER NEW SCHEME TO USE MEDICINAL CANNABIS

In an attempt to stem the seizures in her son Joe, Kaye Dick just started treating her son with medically prescribed cannabis. Joe has suffered severe epilepsy since he was two. Joe is one of the first approved to access medically prescribed cannabis under the State Government’s controlled access scheme.

Wendy Latimer who also suffers from seizures has also been approved to receive the treatment. The 57-year-old suffers one large seizure a day, and about 100 smaller ones. Her family commented that Wendy’s been on almost every medication that is possible and that medical marijuana is probably the last resort to provide her with relief.

Both Joe and Wendy will be monitored by scientists to collect data into the effect of medicinal cannabis.

Read the article here.

 

We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.

READ MORE >

We have successfully passed three consecutive TGO93 and TGO100 tests on our medicinal cannabis products since our first commercial harvest at the end of 2019.

READ MORE >

One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >